| Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons I Katona, B Sperlagh, A Sık, A Käfalvi, ES Vizi, K Mackie, TF Freund Journal of Neuroscience 19 (11), 4544-4558, 1999 | 1490 | 1999 |
| Microglia monitor and protect neuronal function through specialized somatic purinergic junctions C Cserép, B Pósfai, N Lénárt, R Fekete, ZI László, Z Lele, B Orsolits, ... Science 367 (6477), 528-537, 2020 | 592 | 2020 |
| Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection BW Sódar, Á Kittel, K Pálóczi, KV Vukman, X Osteikoetxea, ... Scientific reports 6 (1), 24316, 2016 | 536 | 2016 |
| P2X7 receptors in the nervous system B Sperlágh, ES Vizi, K Wirkner, P Illes Progress in neurobiology 78 (6), 327-346, 2006 | 463 | 2006 |
| P2X7 receptor: an emerging target in central nervous system diseases B Sperlágh, P Illes Trends in pharmacological sciences 35 (10), 537-547, 2014 | 411 | 2014 |
| From purines to purinergic signalling: molecular functions and human diseases Z Huang, N Xie, P Illes, F Di Virgilio, H Ulrich, A Semyanov, A Verkhratsky, ... Signal Transduction and Targeted Therapy 6 (1), 162, 2021 | 328 | 2021 |
| Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus B Sperlágh, A Köfalvi, J Deuchars, L Atkinson, C J. Milligan, NJ Buckley, ... Journal of neurochemistry 81 (6), 1196-1211, 2002 | 327 | 2002 |
| GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus I Katona, B Sperlagh, Z Maglóczky, E Santha, A Köfalvi, S Czirjak, ... Neuroscience 100 (4), 797-804, 2000 | 316 | 2000 |
| Microglia actively remodel adult hippocampal neurogenesis through the phagocytosis secretome I Diaz-Aparicio, I Paris, V Sierra-Torre, A Plaza-Zabala, ... Journal of Neuroscience 40 (7), 1453-1482, 2020 | 308 | 2020 |
| Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis A Köfalvi, RJ Rodrigues, C Ledent, K Mackie, ES Vizi, RA Cunha, ... Journal of Neuroscience 25 (11), 2874-2884, 2005 | 275 | 2005 |
| P2X3 Receptor Involvement in Pain States K Wirkner, B Sperlagh, P Illes Molecular neurobiology 36, 165-183, 2007 | 235 | 2007 |
| The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects B Sperlágh, E Sylvester Vizi Current topics in medicinal chemistry 11 (8), 1034-1046, 2011 | 190 | 2011 |
| ATP released by LPS increases nitric oxideproduction in raw 264.7 macrophage cell line viaP2Z⧹ P2X7 receptors B Sperlágh, G Haskó, Z Németh, ES Vizi Neurochemistry international 33 (3), 209-215, 1998 | 176 | 1998 |
| Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions E Császár, N Lénárt, C Cserép, Z Környei, R Fekete, B Pósfai, D Balázsfi, ... Journal of Experimental Medicine 219 (3), 2022 | 166 | 2022 |
| Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms R Fekete, C Cserép, N Lénárt, K Tóth, B Orsolits, B Martinecz, E Méhes, ... Acta neuropathologica 136, 461-482, 2018 | 154 | 2018 |
| Neuronal synthesis, storage and release of ATP B Sperlágh, SE Vizi Seminars in Neuroscience 8 (4), 175-186, 1996 | 144 | 1996 |
| Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors C Csölle, M Baranyi, G Zsilla, A Kittel, F Gölöncsér, P Illes, E Papp, ... PloS one 8 (6), e66547, 2013 | 141 | 2013 |
| Microglia and the purinergic signaling system S Calovi, P Mut-Arbona, B Sperlágh Neuroscience 405, 137-147, 2019 | 139 | 2019 |
| Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and … P Dunkel, CLL Chai, B Sperlágh, PB Huleatt, P Mátyus Expert opinion on investigational drugs 21 (9), 1267-1308, 2012 | 136 | 2012 |
| Purinergic mechanisms in neuroinflammation: an update from molecules to behavior E Beamer, F Gölöncsér, G Horváth, K Bekő, L Otrokocsi, B Koványi, ... Neuropharmacology 104, 94-104, 2016 | 131 | 2016 |
